Dozens of lawsuits have been filed against the companies behind popular GLP-1 drugs Ozempic, Wegovy and Zepbound, claiming the drugs led to a rare type of vision loss.
ABC News’ Elizabeth Schulze reports.
New lawsuits claim GLP-1 drugs led to vision loss
Dozens of lawsuits have been filed against the companies behind popular GLP-1 drugs Ozempic, Wegovy and Zepbound, claiming the drugs led to a rare type of vision loss.
